Home - GVN

Wall Street Journal: An Old Vaccine May Help Against Coronavirus
Op-ed by GVN’s Dr. Robert Gallo and Daniel Arbess

Read More
GVN SARS-CoV-2 Perspectives: On the Surface, Using a Good Disinfection Strategy Matters
June 29, 2020

Read More
GVN: Forefront Of Virology COVID-19 Webinar Series Featuring Dr. Johan Neyts
The Battle of Leuven Against SARS-CoV-2: Antiviral strategies, vaccine development, and the hamster model

Watch the Webinar Now
New York Times Op-ed - Dr. Robert Gallo: The Case for a Stopgap Vaccine
A polio vaccine may be an ideal solution until we find a Covid-specific vaccine

Read more
Dr. Brechot’s Coronavirus Blog - June 24, 2020
Dexamethasone: Has an old drug ushered in a new era?

Read More
SARS-CoV-2 GVN Center Spotlight: Pontiano Kaleebu
Dr. Pontiano Kaleebu of the Uganda Virus Research Institute (UVRI) discusses their coronavirus response and leading efforts on diagnostics

Read More
GVN’s Position Regarding the Risk of COVID-19 Transmission by Asymptomatic Infected Subjects.
GVN issues a statement on the distinction between asymptomatic and pre-symptomatic transmission

Read Now
TWO CENTERS OF EXCELLENCE OF THE GLOBAL VIRUS NETWORK INDEPENDENTLY VERIFY AN ANTIMICROBIAL TECHNOLOGY THAT ERADICATES SARS-CoV-2 ON SURFACES FOR MORE THAN SIX WEEKS
Global Virus Network Also Advances The Study Of The Oral Polio Vaccine As A Preventive Measure Against SARS-CoV-2

Read More
GLOBAL VIRUS NETWORK HOSTS SIXTH SHORT COURSE
Top GVN Experts Inspire Rising International Virologists

Learn More
Africa GVN meeting in Entebbe
In the Midst of the Second Worst Ebola Outbreak Since Its Discovery, Top African Scientists Identify Ways to Battle Deadly Diseases Together

Learn More

1 2 3 4 5 6 7 8 9 10

About

Learn more about GVN’s mission, leadership, and history.

About GVN

Research

Fighting disease through Research and Training.

Zika Task Force

HTLV-1 Task Force

Chikungunya Task Force

Support

Help GVN increase our impact around the world.

Support GVN

Dr. Robert Gallo…

“Since our lab co-discovered HIV as the cause of AIDS and developed the HIV blood test, I have strongly believed mankind will best be served if the world’s leading virologists are organized and better-equipped to deal with new and existing viral threats. ”

Robert C. Gallo, MD

Co-Founder & International Scientific Advisor, GVN

The Homer and Martha Gudelsky Distinguished Professor in Medicine

Co-Founder & Director, Institute of Human Virology at the University of Maryland School of Medicine

Dr. Christian Bréchot

“I am very proud to be President of the Global Virus Network. This large network offers a unique opportunity to gather the best scientists worldwide and reinforce the fight against the threat of viral infections and epidemics, collaborating with the national and international institutions which are at stake.”

Christian Bréchot, MD, PHD

President

Global Virus Network (GVN)

55 Centers of Excellence

10 Affiliated Institutions

in 33 Countries

Stay up to date